LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Is LeMaitre Vascular's Drop an Opportunity After Expansion and Regulatory News? [Yahoo! Finance]
LeMaitre Vascular (LMAT): A Fresh Look at Valuation After Recent Share Price Weakness [Yahoo! Finance]
LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.